Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Preannounces Q4 Revenues of $33.4M

NEW YORK (GenomeWeb) – Fluidigm said after the close of the market on Tuesday that its revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million.

On average, analysts were expecting Q4 revenues of $33.3 million for the South San Francisco, Calif.-based life science analytical and preparatory systems firm.

Organic revenue for Q4 — excluding revenue attributable to its acquisition of DVS Sciences in January 2014 — is expected to be approximately $25.2 million, which would be a 21 percent increase over the $20.9 million in revenues recorded by the company in Q4 2013.

Meantime, Fluidigm said that total revenue for full-year 2014 is expected to be $116.4 million, while organic revenue, less DVS Sciences' contribution, is expected to be $95.9 million.

Fluidigm projects total revenue of between $142 million and $149 million for full-year 2015. These projections incorporate an estimated negative currency-related impact of 3 percent to 4 percent at the midpoint of the range.

"We achieved strong sequential growth within our CyTOF single-cell proteomics product line both in terms of revenue and bookings," Fluidigm CEO Gajus Worthington said in a statement. "Our full-year results are at the high end of our previously stated guidance, despite a currency headwind in the quarter. As in the third quarter, we realized commercial synergy between single-cell genomics and proteomics at a customer and sales representative level."

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.